Superior Planning, LLC’s Jade Biosciences JBIO Stock Holding History

Superior Planning, LLC’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14	Buy	+1	New	+$20	﹤0.01%	2133

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Superior Planning, LLC's JBIO Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Jade Biosciences (JBIO) in Q3 2026: 1 share worth $14. The stake represents ﹤0.01% of the portfolio and ranks #2133 among its holdings.

70 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

Superior Planning, LLC held 1 share of Jade Biosciences worth $14 as of Q3 2026.
Jade Biosciences was a new Superior Planning, LLC position in Q3 2026.
Jade Biosciences made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #2133 holding.
70 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.